Blood test guides safer cancer treatment after surgery

NCT ID NCT06445114

Recruiting now Disease control Sponsor: Zachary Zumsteg Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This study tests whether a blood test that detects tumor DNA can help doctors choose the right amount of chemotherapy and radiation after surgery for HPV-positive throat cancer. The goal is to give less intense treatment to patients with a low risk of cancer returning, reducing side effects. About 50 adults with early-stage HPV-related oropharyngeal cancer will participate.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma oropharyngeal carcinoma oropharynx cancer oropharynx squamous cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARCINOMA OROPHARYNGEAL CANCER

Contacts and locations

Locations

CS Cancer at Valley Oncology Medical Group
RECRUITING

Tarzana, California, 91356, United States
CS Cancer at the Hunt Cancer Center
RECRUITING

Torrance, California, 90505, United States
Cedars Sinai Medical Center
RECRUITING

Los Angeles, California, 90048, United States
Cedars-Sinai Cancer at Beverly Hills (THO)
RECRUITING

Beverly Hills, California, 90211, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.